Cargando…
The Present State of Lithium for the Prevention of Dementia Related to Alzheimer’s Dementia in Clinical and Epidemiological Studies: A Critical Review
Despite the unavailability of essential anti-dementia drugs, lithium may inhibit glycogen synthase kinase-3 (GSK-3) and decrease beta-amyloid and hyper-phosphorylated tau. In this review, we hypothesized that trace to standard levels of lithium (i.e., corresponding to the therapeutic levels for bipo...
Autores principales: | Ishii, Nobuyoshi, Terao, Takeshi, Hirakawa, Hirofumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345730/ https://www.ncbi.nlm.nih.gov/pubmed/34360049 http://dx.doi.org/10.3390/ijerph18157756 |
Ejemplares similares
-
Lithium in drinking water and crime rates in Japan: cross-sectional study
por: Kohno, Kentaro, et al.
Publicado: (2020) -
Adjunctive bright light therapy for treating bipolar depression: A systematic review and meta‐analysis of randomized controlled trials
por: Hirakawa, Hirofumi, et al.
Publicado: (2020) -
Case of drug eruption during treatment with lithium and lamotrigine implicating a possible role of additives in the lithium tablet
por: Kugimiya, Tsuyoshi, et al.
Publicado: (2019) -
Relationship between ambient light and glucose metabolism in healthy subjects
por: Hirakawa, Hirofumi, et al.
Publicado: (2018) -
The Financial Presentation of Alzheimer’s Disease and Related Dementias
por: Nicholas, Lauren
Publicado: (2020)